首页 | 本学科首页   官方微博 | 高级检索  
检索        

降纤酶治疗椎基底动脉供血不足的临床疗效
引用本文:鲁佑瑜,凌振芬,吴云成,胡乐娴.降纤酶治疗椎基底动脉供血不足的临床疗效[J].中国临床药学杂志,2002,11(6):347-349.
作者姓名:鲁佑瑜  凌振芬  吴云成  胡乐娴
作者单位:上海市第一人民医院神经内科,上海,200080
摘    要:目的:观察降纤酶治疗椎基底动脉供血不足(VBI)的疗效。方法:52例VBI患者分为治疗组(降纤酶加常规药物治疗,28例)和常规组(常规治疗:相对低分子质量右旋糖酐+复方丹参静脉点滴,24例)。结果:治疗后,治疗组和常规组的显效率分别为57%和38%(P<0.05),总有效率分别为86%和58%(P<0.05)。结论:加用降纤酶治疗VBI可显著提高疗效。值得临床推广。

关 键 词:降纤酶  治疗  椎基底动脉供血不足  临床  疗效
文章编号:1007-4406(2002)06-0347-03

Efficacy of defibrin in treatment of patients with vertebro-basilar artery insufficiency
Lu Youyu,Ling Zhenfen,Wu Yuncheng,Hu Lexian.Efficacy of defibrin in treatment of patients with vertebro-basilar artery insufficiency[J].Chinese Journal of Clinical Pharmacy,2002,11(6):347-349.
Authors:Lu Youyu  Ling Zhenfen  Wu Yuncheng  Hu Lexian
Abstract:AIM: To evaluate the efficacy of defibrin in the patients with vertebro-basilar artery insufficiency (VBI). METHODS: Fifty-two patients with VBI were divided into treatment group (n=28, defibrin adding routine drugs) and control group (n=24, routine therapy: relative low molecular mass dextran adding Danshen root compound, iv gtt). RESULTS: Significant effective rate (57%), total effective rate (86%) in treatment group after therapy was remarkable higher than those in control group (P<0.05). CONCLUSION: Defibrin is considered effects in treatment of VBI.
Keywords:defibrin  vertebro-basilar artery insufficiency  effect
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号